Nanexa Stock price
AI Insights on Nanexa
Insights
Is Nanexa a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.
Key metrics
Nanexa Events
Upcoming Event
Don't miss a Thing! We will send you all news about Nanexa directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Nanexa AB engages in the development, production, and distribution of medical nanotechnology products. The firm specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.
| Head office | Sweden |
| CEO | David Westberg |
| Employees | 16 |
| Website | nanexa.com |


